Read More Pharma Industry News Recce Pharmaceuticals secures approval for Phase 3 trial of R327G in Indonesia Recce Pharmaceuticals Limited (ASX: RCE) has achieved a significant milestone in its quest to tackle diabetic foot infections… byPallavi MadhirajuDecember 9, 2024